Cite
APA Citation
Papadopoulos, K. P., Tsai, F., Hamid, O., Xiao, F., Steele, K. E., Rebelatto, M. C., Robbins, P. B., Karakunnel, J. J., Lai, D. W., & Mahipal, A. (n.d.). a Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. Journal for immunotherapy of cancer, 3, . http://access.bl.uk/ark:/81055/vdc_100135571502.0x000006